Bill

Bill > SB1626


TN SB1626

TN SB1626
AN ACT to amend Tennessee Code Annotated, Title 4; Title 56 and Title 71, relative to cancer testing.


summary

Introduced
01/13/2026
In Committee
Crossed Over
Passed
Dead

Introduced Session

114th General Assembly

Bill Summary

As introduced, requires that a health plan, or an insurer offering a health plan, include coverage for clinical genetic testing for an inherited gene mutation for an individual with a personal or family history of cancer that is recommended by a healthcare professional, and evidence-based cancer imaging for an individual with an increased risk of cancer as recommended by National Comprehensive Cancer Network clinical practice guidelines. - Amends TCA Title 4; Title 56 and Title 71.

AI Summary

This bill mandates that health plans and insurers in Tennessee must cover clinical genetic testing for inherited gene mutations in individuals with a personal or family history of cancer, provided a healthcare professional recommends it. It also requires coverage for evidence-based cancer imaging for individuals at increased risk, as outlined by the National Comprehensive Cancer Network (NCCN) clinical practice guidelines. Importantly, these required coverages cannot be subject to any out-of-pocket expenses like deductibles or copayments, though there are specific provisions for high-deductible health plans to maintain eligibility for health savings accounts under federal law.

Committee Categories

Budget and Finance, Business and Industry

Sponsors (2)

Last Action

Recommended for passage with amendment/s, refer to Senate Finance, Ways, and Means Committee Ayes 5, Nays 3 PNV 1 (on 02/24/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...